From: Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer
Clinicopathological data | All patients (n = 235) |
---|---|
Age (year), mean ± SD | 66.87 ± 8.53 |
PSA (ng/mL), median (range) | 4.65 (0.22–86.00) |
PCa, n (%) | 122 (51.9) |
csPCa, n (%) | 99 (42.1) |
Gleason score, n (%) | |
 3 + 3 | 23 (9.8) |
 3 + 4 | 42 (17.8) |
 4 + 3 | 25 (10.6) |
 3 + 5 | 1 (0.4) |
 4 + 4 | 9 (3.8) |
 4 + 5 | 15 (6.4) |
 5 + 4 | 5 (2.1) |
 5 + 5 | 2 (0.9) |